Depósito Digital de Documentos de la UAB Encontrados 7 registros  La búsqueda tardó 0.02 segundos. 
1.
10 p, 440.1 KB Direct medical costs attributable to type 2 diabetes mellitus : a population-based study in Catalonia, Spain / Mata Cases, Manel (CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM)) ; Casajuana, Marc (Universitat Autònoma de Barcelona) ; Franch Nadal, Josep (Institut Català de la Salut) ; Casellas, Aina (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Castell, Conxa (Generalitat de Catalunya. Departament de Salut) ; Vinagre Torres, Irene (Universitat de Barcelona) ; Mauricio Puente, Dídac (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Bolíbar, Bonaventura (Universitat Autònoma de Barcelona)
We estimated healthcare costs associated with patients with type 2 diabetes compared with non-diabetic subjects in a population-based primary care database through a retrospective analysis of economic impact during 2011, including 126,811 patients with type 2 diabetes in Catalonia, Spain. [...]
2016 - 10.1007/s10198-015-0742-5
The European Journal of Health Economics, Vol. 17, Issue 8 (November 2016) , p. 1001-1010  
2.
34 p, 1.7 MB Reputational concerns with altruistic providers / Olivella, Pau (Universitat Autònoma de Barcelona. Departament d'Economia) ; Siciliani, Luigi (University of York. Department of Economics and Related Studies)
We study a model of reputational concerns when doctors differ in their degree of altruism and they can signal their altruism by their (observable) quality. When reputational concerns are high, following the introduction or enhancement of public reporting, the less altruistic (bad) doctor mimics the more altruistic (good) doctor. [...]
2017 - 10.1016/j.jhealeco.2017.05.003
Journal of health economics, 2017  
3.
19 p, 207.6 KB Negotiation advantages of professional associations in health care / Barros, Pedro Pita (Universidade Nova de Lisboa) ; Martínez Giralt, Xavier (Universitat Autònoma de Barcelona. Departament d'Economia)
In several instances, third-party payers negotiate prices of health care services with providers. We show that a third-party payer may prefer to deal with a professional association than with the sub-set constituted by the more efficient providers, and then apply the same price to all providers. [...]
2005 - 10.1007/s10754-005-1867-3
International journal of health care finance and economics, Vol. 5 Núm. 2 (2005) , p. 191-204  
4.
19 p, 585.5 KB On international cost-sharing of pharmaceutical R&D / Barros, Pedro Pita (Universidade Nova de Lisboa) ; Martinez Giralt, Xavier (Universitat Autònoma de Barcelona)
Ramsey pricing has been proposed in the pharmaceutical industry as a principle to price discriminate among markets while allowing to recover the (fixed) R&D cost. However, such analyses neglect the presence of insurance or the fund raising costs for most of drug reimbursement. [...]
2008 - 10.1007/s10754-008-9042-2
International journal of health care finance and economics, Vol. 8, Num. 4 (Dec 2008) , p. 301-312  
5.
37 p, 731.5 KB Contractual design and PPPs for hospitals : lessons for the Portuguese model / Pita Barros, Pedro (Universidade Nova de Lisboa) ; Martinez Giralt, Xavier (Universitat Autònoma de Barcelona. Departament d'Economia)
Recently the Portuguese Government announced the launching of public–private partnerships (PPPs) to build hospitals with the distinctive feature that infrastructure construction and clinical activities management will be awarded to separate private parties. [...]
2009 - 10.1007/s10198-009-0152-7
The European journal of health economics, Vol. 10 Núm. 4 (October 2009) , p. 437-453  
6.
43 p, 1.1 MB A theoretical approach to dual practice regulations in the health sector / González, Paula (Universidad Pablo de Olavide.) ; Macho-Stadler, Inés (Universitat Autònoma de Barcelona. Departament d'Economia)
Internationally, there is wide cross-country heterogeneity in government responses to dual practice in the health sector. This paper provides a uniform theoretical framework to analyze and compare some of the most common regulations. [...]
2013 - 10.1016/j.jhealeco.2012.08.005
Journal of health economics, Vol. 32, Num. 1 (2013) , p. 66-87  
7.
32 p, 678.6 KB Private versus social incentives for pharmaceutical innovation / González, Paula (Universidad Pablo de Olavide) ; Macho-Stadler, Inés (Universitat Autònoma de Barcelona. Departament d'Economia i d'Història Econòmica) ; Pérez-Castrillo, David (Universitat Autònoma de Barcelona. Departament d'Economia i d'Història Econòmica)
We provide a theoretical framework to contribute to the current debate regarding the tendency of pharmaceutical companies to direct their R&D toward marketing products that are follow-on drugs of already existing drugs, rather than toward the development of breakthrough drugs. [...]
2016 - 10.1016/j.jhealeco.2015.12.003
Journal of health economics, Vol. 50 (2016) , p. 286-297  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.